4.7 Letter

Inclusion of drugs on the World Health Organization's Essential Medicines List: A game-changer for obesity?

Journal

DIABETES OBESITY & METABOLISM
Volume 25, Issue 8, Pages 2423-2424

Publisher

WILEY
DOI: 10.1111/dom.15114

Keywords

anti-obesity drugs; liraglutide; long-term effects; low and middle-income countries; price transparency; semaglutide

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available